期刊文献+

Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases 被引量:8

Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases
下载PDF
导出
摘要 Discoveries in the first few years of the 21st century have led to an understanding of important interactions between the nervous system and the inflammatory response at the molecular level, most notably the acetylcholine (ACh)- triggered, a7-nicotinic acetylcholine receptor (a7nAChR)- dependent nicotinic anti-inflammatory pathway. Studies using the a7nAChR agonist, nicotine, for the treatment of mucosal inflammation have been undertaken but the efficacy of nicotine as a treatment for inflammatory bowel diseases remains debatable. Further understanding of the nicotinic anti-inflammatory pathway and other endogenous anti-inflammatory mechanisms is required in order to develop refined and specific therapeutic strategies for the treatment of a number of inflammatory diseases and conditions, including periodontitis, psoriasis, sarcoidosis, and ulcerative colitis. Discoveries in the first few years of the 21st century have led to an understanding of important interactions between the nervous system and the inflammatory response at the molecular level, most notably the acetylcholine (ACh)- triggered,α7-nicotinic acetylcholine receptor (α7nAChR)- dependent nicotinic antinflammatory pathway. Studies using the α7nAChR agonist, nicotine, for the treatment of mucosal inflammation have been undertaken but the efficacy of nicotine as a treatment for inflammatory bowel diseases remains debatable. Further understanding of the nicotinic anti-inflammatory pathway and other endogenous anti-inflammatory mechanisms is required in order to develop refined and specific therapeutic strategies for the treatment of a number of inflammatory diseases and conditions, including periodontitis, psoriasis, sarcoidosis, and ulcerative colitis.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第46期7451-7459,共9页 世界胃肠病学杂志(英文版)
关键词 抽烟 烟碱 抗炎作用 细胞通路 上皮 炎症 治疗 α7-nicotinic acetylcholine receptor Inflammation Mucosa Nicotine Nicotinic anti-inflammatory pathway Tobacco smoking
  • 相关文献

参考文献90

  • 1[1]Eriksson MO,Hagforsen E,Lundin IP,Michaelsson G.Palmoplantar pustulosis:a clinical and immunohistological study.Br J Dermatol 1998; 138:390-398
  • 2[2]Fortes C,Mastroeni S,Leffondre K,Sampogna F,Melchi F,Mazzotti E,Pasquini P,Abeni D.Relationship between smoking and the clinical severity of psoriasis.Arch Dermatol 2005; 141:1580-1584
  • 3[3]Hagforsen E,Edvinsson M,Nordlind K,Michaelsson G.Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis.Br J Dermatol 2002; 146:383-391
  • 4[4]Calkins BM.A meta-analysis of the role of smoking in inflammatory bowel disease.Dig Dis Sci 1989; 34:1841-1854
  • 5[5]Johnson GJ,Cosnes J,Mansfield JC.Review article:smoking essation as primary therapy to modify the course of Crohn's disease.Aliment Pharmacol Ther 2005; 21:921-931
  • 6[6]Thomas GA,Rhodes J,Ingram JR.Mechanisms of disease:nicotine -a review of its actions in the context of gastrointestinal disease.Nat Clin Pract Gastroenterol Hepatol 2005; 2:536-544
  • 7[7]Merrett MN,Mortensen N,Kettlewell M,Jewell DO.Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis.Gut 1996; 38:362-364
  • 8[8]Snook JA,Dwyer L,Lee-Elliott C,Khan S,Wheeler DW,Nicholas DS.Adult coeliac disease and cigarette smoking.Gut 1996; 39:60-62
  • 9[9]Scott DA,Singer DL.Suppression of overt gingival inflammation in tobacco smokers-clinical and mechanistic considerations.Int J Dent Hyg 2004; 2:104-110
  • 10[10]Nair P,Sutherland G,Palmer RM,Wilson RF,Scott DA.Gingival bleeding on probing increases after quitting smoking.J Clin Periodontol 2003; 30:435-437

同被引文献75

引证文献8

二级引证文献155

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部